ARTIVION INC
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On March 13, 2025 Amy D. Horton, our Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement, pursuant to which she may sell up to 7,992 shares of the Company's common stock. The duration of the trading arrangement is from June 12, 2025 to March 5, 2026. On March 14, 2025 Marshall S. Stanton, our Chief Medical Officer, adopted a Rule 10b5-1 trading arrangement, pursuant to which he may sell up to 41,132 share of the Company's common stock. The duration of the trading arrangement is from June 13, 2025 to June 13, 2026. These trading arrangements are intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.
No other directors or officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted, modified, orterminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities during the three months ended March 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.